When a stock’s price falls into the doldrums, it’s tempting to just avoid those shares. After all, rock bottom prices usually happen for …
Investors are snapping up Ascendis Pharma A/S (NASDAQ:ASND) shares following the news that competitor somavaratan long-acting growth hormone is no longer a threat. …
Based in Hellerup, Denmark, Ascendis Pharma A/S (Pending:ASND) scheduled a $85 million IPO on Nasdaq with a market capitalization of $373 million at a …
